Scarica l'app Stockscreener
8.74
3.55%
0.30
Precedente Chiudi:
$8.44
Aprire:
$9.04
Volume 24 ore:
3,660
Relative Volume:
0.98
Capitalizzazione di mercato:
$74.11M
Reddito:
$70,100
Utile/perdita netta:
$-9.16M
Rapporto P/E:
-7.9985
EPS:
-1.0927
Flusso di cassa netto:
$-6.67M
1 W Prestazione:
+20.89%
1M Prestazione:
+8.03%
6M Prestazione:
-34.33%
1 anno Prestazione:
-13.64%
Intervallo 1D:
$8.14
$9.04
Intervallo di 1 settimana:
$7.15
$9.04
Portata 52W:
$7.08
$18.40
Exozymes Inc Stock (EXOZ) Company Profile
Nome
Exozymes Inc
Settore
Industria
Telefono
(626) - 415 - 1488
Indirizzo
750 ROYAL OAKS DR, MONROVIA
Compare EXOZ vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EXOZ
Exozymes Inc
|
8.74 | 74.11M | 70,100 | -9.16M | -6.67M | -1.0927 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Exozymes Inc Borsa (EXOZ) Ultime notizie
EXOZ PE Ratio & Valuation, Is EXOZ Overvalued - Intellectia AI
Nasdaq Moves: Is eXoZymes Inc forming a bullish divergenceShare Buyback & High Accuracy Buy Signal Tips - baoquankhu1.vn
EXoZymes Inc (EXOZ) Q4 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges By GuruFocus - Investing.com Canada
eXoZymes Provides Fourth Quarter and Full Year 2025 Update - Bitget
EXOZ: NCT achieved kilo-scale production and tech transfer, with a financing round in progress - TradingView
eXoZymes Inc's Capital Raise Delays and NCT Timeline Shifts Highlight Strategic Contradictions - Bitget
eXoZymes Q4 Earnings Call Highlights - MarketBeat
EXOZ: Pilot-scale NCT production achieved; financing round underway to support 2027 commercial launch - TradingView
Earnings call transcript: eXoZymes Q4 2025 results show strategic focus - Investing.com
eXoZymes ends 2025 with $3.04M cash as financing round nears - stocktitan.net
eXoZymes Updates Investor Presentation for NCTx Business - TipRanks
eXoZymes (NASDAQ: EXOZ) files updated NCTx investor presentation - stocktitan.net
eXoZymes Q4 2025 Earnings Call Transcript - MarketBeat
eXoZymes (NASDAQ: EXOZ) outlines exozyme platform and NCT plans - stocktitan.net
EXoZymes, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Institution Moves: Can eXoZymes Inc sustain earnings growth2026 Geopolitical Influence & Technical Pattern Recognition Alerts - baoquankhu1.vn
eXoZymes to Host Fourth Quarter and Full Year 2025 Results Conference Call on Tuesday March 31, 2026 - ACCESS Newswire
EXOZ Price Today: eXoZymes Inc. Stock Price, Quote & Chart - MEXC Exchange
Whale Trades: Can eXoZymes Inc sustain earnings growthRate Hike & High Accuracy Investment Entry Signals - baoquankhu1.vn
eXoZymes (NASDAQ:EXOZ) Shares Up 2.4%What's Next? - MarketBeat
Momentum Shift: Is eXoZymes Inc forming a bullish divergenceForecast Cut & Reliable Price Action Trade Plans - baoquankhu1.vn
If You Invested $1,000 in eXoZymes Inc (EXOZ) - stocktitan.net
Growth Recap: Whats the beta of eXoZymes Inc stock2026 Top Decliners & Long-Term Safe Return Strategies - baoquankhu1.vn
Aug PostEarnings: What is eXoZymes Incs market positionEarnings Risk Summary & Fast Moving Trade Plans - baoquankhu1.vn
Whale Trades: Will eXoZymes Inc benefit from seasonality2026 Analyst Calls & Technical Pattern Based Signals - baoquankhu1.vn
Successful Pilot Scale Run with Cayman Chemical Validates eXoZymes' Technology and Scalability - ACCESS Newswire
Successful pilot scale run with Cayman Chemical validates eXoZymes' technology and scalability - SynBioBeta
Sell Signal: What are eXoZymes Incs recent SEC filings showing2026 Growth vs Value & Accurate Technical Buy Alerts - baoquankhu1.vn
eXoZymes’ CCO Damien Perriman to Present an NCT Solution at Next Week’s MISTA Symposium - The National Law Review
eXoZymes' CCO Damien Perriman to Present a NCT Solution at Next Week's MISTA Symposium - Bitget
The rare plant molecule eXoZymes is scaling for metabolic health - Stock Titan
Pullback Watch: Does eXoZymes Inc stock have upside surprise potentialJuly 2025 Rallies & Low Volatility Stock Recommendations - baoquankhu1.vn
Head-To-Head Analysis: eXoZymes (NASDAQ:EXOZ) & Curis (NASDAQ:CRIS) - Defense World
Latest EXOZ NewseXoZymes Provides First Quarter 2025 and NC... - stocktitan.net
Molecular Partners (NASDAQ:MOLN) and eXoZymes (NASDAQ:EXOZ) Head-To-Head Analysis - Defense World
With Refreshed Brand eXoZymes Sharpens Pharmaceutical Focus to Drive Platform Leverage and Long-Term Value - EIN News
Is eXoZymes Inc backed by strong institutional buyingWeekly Profit Recap & Precise Trade Entry Recommendations - baoquankhu1.vn
Travel Stocks: Does eXoZymes Inc stock have upside surprise potentialJuly 2025 Big Picture & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Market Recap: Can Kearny Financial Corp withstand a market correctionJuly 2025 Sector Moves & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Algo Trading Space Launches Space Tracker: Advanced Trading Journal and Analytics Platform for VIP Members - MetroWest Daily News
Institution Moves: Is eXoZymes Inc a speculative investmentMarket Performance Report & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
EXOZ Financials: Income Statement, Balance Sheet & Cash Flow | eXoZymes Inc - stocktitan.net
Will eXoZymes Inc. stock continue upward momentumBond Market & Target Return Focused Picks - mfd.ru
Does eXoZymes Inc. stock reflect fundamentalsJuly 2025 Snapshot & Weekly Setup with High ROI Potential - mfd.ru
Does eXoZymes Inc. stock have upside surprise potentialSell Signal & Weekly Top Gainers Alerts - mfd.ru
eXoZymes unveils new website and branding to reflect pharma focus By Investing.com - Investing.com South Africa
Quarterly Earnings: What chart patterns are forming on eXoZymes IncMarket Risk Analysis & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
eXoZymes unveils new website and branding to reflect pharma focus - Investing.com
With Refreshed Brand eXoZymes Sharpens Pharmaceutical Focus to Drive Platform Leverage and Long-Term Value Creation - ACCESS Newswire
Exozymes Inc Azioni (EXOZ) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):